
Building Biotech: From the Lab to the Boardroom | Raj Devraj, CEO of Rectify Pharma
Nucleate Podcast
00:00
Navigating Biotech Strategy and Partnerships
This chapter explores strategic decisions in biotech regarding indication selection, particularly for hepatobiliary diseases, highlighting scientific validation and genetic factors. It underscores the importance of building strong partnerships with pharmaceutical companies and the dynamics of successful collaborations in drug development. The discussion also contrasts the operational agility of biotech firms with the extensive resources of larger pharma, emphasizing the need for strategic planning and relationship-building in a competitive landscape.
Transcript
Play full episode